Oki Inflammation and Pain Spray 15 ml

WARNINGS
The use, especially if prolonged, of topical drugs could give rise to sensitization phenomena, in which case it is necessary to suspend the treatment and adopt suitable therapeutic measures. The medicine contains methyl para-hydroxybenzoate, known for the possibility of causing allergic reactions (even delayed).
PHARMACOTHERAPEUTIC CATEGORY
Dental.
STORAGE
No special instructions.
CONTRAINDICATIONS / SECONDARY EFFECT
The medicine must not be administered in case of hypersensitivity to the active substance, to other non-steroidal anti-inflammatory drugs (NSAIDs) or to any of the excipients, to patients in whom substances with a similar mechanism of action (for example acetylsalicylic acid or other NSAIDs ) cause asthma attacks, bronchospasm, acute rhinitis, or cause nasal polyps, urticaria or angioneurotic edema, in case of previous bronchial asthma, during pregnancy and breastfeeding.
NAME
OKI INFLAMMATION AND PAIN 0.16% SPRAY FOR ORAL MUCOSA
EXCIPIENTS
Glycerol 85%, xylitol, methyl para-hydroxybenzoate, monobasic sodium phosphate, poloxamer 407, mint flavor, purified water.
SIDE EFFECTS
Local side effects following the topical administration on the oral mucosa of ketoprofen lysine salt solution are extremely rare and consist of irritative or allergic phenomena (angioneurotic edema) especially in subjects with hypersensitivity to NSAIDs. However, no systemic side effects emerged considering the route of administration and the dosage of drug administered.
PREGNANCY AND BREASTFEEDING
As with other non-steroidal anti-inflammatory drugs, the product should not be used in case of known or suspected pregnancy and during breastfeeding.
INDICATIONS
Symptomatic treatment of irritative-inflammatory states also associated with pain in the oropharyngeal cavity (eg gingivitis, stomatitis, pharyngitis), also as a consequence of conservative or extractive dental therapy.
INTERACTIONS
At present there are no known interactions with other drugs: interactions that can also be excluded considering the route of administration and the dosage of drug administered.
DOSAGE
1-2 sprays up to 3 times a day, addressed directly to the affected area. Each spray delivers approximately 0.2 ml of solution, equivalent to 0.32 mg of active ingredient.
ACTIVE PRINCIPLES
Ketoprofen.